36613503|t|Alpha-Lipoic Acid and Its Enantiomers Prevent Methemoglobin Formation and DNA Damage Induced by Dapsone Hydroxylamine: Molecular Mechanism and Antioxidant Action.
36613503|a|Dapsone (DDS) therapy can frequently lead to hematological side effects, such as methemoglobinemia and DNA damage. In this study, we aim to evaluate the protective effect of racemic alpha lipoic acid (ALA) and its enantiomers on methemoglobin induction. The pre- and post-treatment of erythrocytes with ALA, ALA isomers, or MB (methylene blue), and treatment with DDS-NOH (apsone hydroxylamine) was performed to assess the protective and inhibiting effect on methemoglobin (MetHb) formation. Methemoglobin percentage and DNA damage caused by dapsone and its metabolites were also determined by the comet assay. We also evaluated oxidative parameters such as SOD, GSH, TEAC (Trolox equivalent antioxidant capacity) and MDA (malondialdehyde). In pretreatment, ALA showed the best protector effect in 2.5 microg/mL of DDS-NOH. ALA (1000 microM) was able to inhibit the induced MetHb formation even at the highest concentrations of DDS-NOH. All ALA tested concentrations (100 and 1000 microM) were able to inhibit ROS and CAT activity, and induced increases in GSH production. ALA also showed an effect on DNA damage induced by DDS-NOH (2.5 microg/mL). Both isomers were able to inhibit MetHb formation and the S-ALA was able to elevate GSH levels by stimulating the production of this antioxidant. In post-treatment with the R-ALA, this enantiomer inhibited MetHb formation and increased GSH levels. The pretreatment with R-ALA or S-ALA prevented the increase in SOD and decrease in TEAC, while R-ALA decreased the levels of MDA; and this pretreatment with R-ALA or S-ALA showed the effect of ALA enantiomers on DNA damage. These data show that ALA can be used in future therapies in patients who use dapsone chronically, including leprosy patients.
36613503	0	17	Alpha-Lipoic Acid	Chemical	MESH:D008063
36613503	46	59	Methemoglobin	Gene	3048
36613503	78	84	Damage	Disease	MESH:D020263
36613503	96	117	Dapsone Hydroxylamine	Chemical	MESH:C018209
36613503	163	170	Dapsone	Chemical	MESH:D003622
36613503	172	175	DDS	Chemical	MESH:C007792
36613503	244	261	methemoglobinemia	Disease	MESH:D008708
36613503	270	276	damage	Disease	MESH:D020263
36613503	345	362	alpha lipoic acid	Chemical	MESH:D008063
36613503	364	367	ALA	Chemical	MESH:D008063
36613503	392	405	methemoglobin	Gene	3048
36613503	466	469	ALA	Chemical	MESH:D008063
36613503	471	474	ALA	Chemical	MESH:D008063
36613503	487	489	MB	Chemical	MESH:D008751
36613503	491	505	methylene blue	Chemical	MESH:D008751
36613503	527	534	DDS-NOH	Chemical	MESH:C018209
36613503	536	556	apsone hydroxylamine	Chemical	-
36613503	622	635	methemoglobin	Gene	3048
36613503	637	642	MetHb	Gene	3048
36613503	655	668	Methemoglobin	Gene	3048
36613503	688	694	damage	Disease	MESH:D020263
36613503	705	712	dapsone	Chemical	MESH:D003622
36613503	821	824	SOD	Gene	6647
36613503	826	829	GSH	Chemical	MESH:D005978
36613503	881	884	MDA	Chemical	MESH:D008315
36613503	886	901	malondialdehyde	Chemical	MESH:D008315
36613503	921	924	ALA	Chemical	MESH:D008063
36613503	978	985	DDS-NOH	Chemical	MESH:C018209
36613503	987	990	ALA	Chemical	MESH:D008063
36613503	1037	1042	MetHb	Gene	3048
36613503	1091	1098	DDS-NOH	Chemical	MESH:C018209
36613503	1104	1107	ALA	Chemical	MESH:D008063
36613503	1173	1176	ROS	Chemical	-
36613503	1181	1184	CAT	Gene	847
36613503	1220	1223	GSH	Chemical	MESH:D005978
36613503	1236	1239	ALA	Chemical	MESH:D008063
36613503	1269	1275	damage	Disease	MESH:D020263
36613503	1287	1294	DDS-NOH	Chemical	MESH:C018209
36613503	1346	1351	MetHb	Gene	3048
36613503	1370	1375	S-ALA	Chemical	MESH:D008063
36613503	1396	1399	GSH	Chemical	MESH:D005978
36613503	1485	1490	R-ALA	Chemical	MESH:D008063
36613503	1518	1523	MetHb	Gene	3048
36613503	1548	1551	GSH	Chemical	MESH:D005978
36613503	1582	1587	R-ALA	Chemical	MESH:D008063
36613503	1591	1596	S-ALA	Chemical	MESH:D008063
36613503	1623	1626	SOD	Gene	6647
36613503	1655	1660	R-ALA	Chemical	MESH:D008063
36613503	1685	1688	MDA	Chemical	MESH:D008315
36613503	1717	1722	R-ALA	Chemical	MESH:D008063
36613503	1726	1731	S-ALA	Chemical	MESH:D008063
36613503	1753	1756	ALA	Chemical	MESH:D008063
36613503	1776	1782	damage	Disease	MESH:D020263
36613503	1805	1808	ALA	Chemical	MESH:D008063
36613503	1844	1852	patients	Species	9606
36613503	1861	1868	dapsone	Chemical	MESH:D003622
36613503	1892	1899	leprosy	Disease	MESH:D007918
36613503	1900	1908	patients	Species	9606
36613503	Negative_Correlation	MESH:D008063	MESH:D020263
36613503	Positive_Correlation	MESH:C007792	MESH:D008708
36613503	Negative_Correlation	MESH:D008063	3048
36613503	Negative_Correlation	MESH:D008063	847
36613503	Positive_Correlation	MESH:C018209	MESH:D020263
36613503	Positive_Correlation	MESH:C018209	3048
36613503	Association	MESH:C018209	MESH:D008063
36613503	Positive_Correlation	MESH:D005978	MESH:D008063
36613503	Negative_Correlation	MESH:D003622	MESH:D007918
36613503	Positive_Correlation	MESH:D003622	MESH:D020263
36613503	Positive_Correlation	MESH:D003622	MESH:D008708
36613503	Negative_Correlation	MESH:D008063	6647

